Biondvax Pharma ADR (BVXV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BVXV | AZN | AMGN | GILD | BMY |
| Company | Biondvax Pharma ADR | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 1.3200 | 204.60 | 375.26 | 148.93 | 60.97 |
| High | 1.3700 | 207.34 | 381.78 | 152.46 | 61.44 |
| Low | 1.3200 | 204.22 | 374.74 | 148.38 | 60.64 |
| Latest | 1.3600 | 204.94 | 379.42 | 149.83 | 61.25 |
| Change | +0.0500 | +0.74 | +4.67 | -1.57 | +0.59 |
| % Change | +3.82% | +0.36% | +1.25% | -1.04% | +0.97% |
| Volume | 23,000 | 1,816,200 | 2,951,600 | 5,994,700 | 11,029,000 |
| 20-Day Average Volume | 12,760 | 2,889,805 | 3,067,970 | 8,059,700 | 13,147,920 |
| Previous Close | 1.3100 | 204.20 | 374.75 | 151.40 | 60.66 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.3207 | 195.47 | 362.74 | 147.80 | 58.48 |
| 20-Day Raw Stochastic | 78.57% | 73.28% | 87.89% | 68.39% | 89.80% |
| 20-Day Relative Strength | 49.42 | 62.04 | 63.93 | 61.54 | 65.69 |
| Weighted Alpha | -64.90 | +43.60 | +32.72 | +41.33 | +16.84 |
| Today's Opinion | 88% Sell | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 100% Sell | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 100% Sell | 80% Buy | 88% Buy | 100% Buy | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | unch since 08/29/23 | -0.30% since 02/13/26 | +2.77% since 02/13/26 | -3.32% since 02/13/26 | +0.84% since 02/13/26 |
| Low | 1.3000 on 09/01/23 | 204.05 on 02/20/26 | 369.00 on 02/17/26 | 148.38 on 02/23/26 | 59.23 on 02/19/26 |
| High | 1.3700 on 09/06/23 | 212.71 on 02/18/26 | 381.78 on 02/23/26 | 156.01 on 02/18/26 | 61.44 on 02/23/26 |
| 1-Month | |||||
| %Chg | -1.45% since 08/04/23 | +10.24% since 01/23/26 | +10.06% since 01/23/26 | +10.23% since 01/23/26 | +12.08% since 01/23/26 |
| Low | 1.2500 on 08/22/23 | 183.63 on 02/03/26 | 338.07 on 01/30/26 | 133.69 on 01/26/26 | 54.21 on 01/29/26 |
| High | 1.3900 on 08/28/23 | 212.71 on 02/18/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 62.05 on 02/06/26 |
| 3-Month | |||||
| %Chg | -5.00% since 06/06/23 | +12.60% since 11/21/25 | +12.41% since 11/21/25 | +18.31% since 11/21/25 | +32.43% since 11/21/25 |
| Low | 1.2500 on 08/22/23 | 178.08 on 01/21/26 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 47.58 on 11/24/25 |
| High | 1.8703 on 07/12/23 | 212.71 on 02/18/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 62.05 on 02/06/26 |
| 6-Month | |||||
| %Chg | -40.09% since 03/06/23 | +26.55% since 08/22/25 | +29.18% since 08/22/25 | +30.55% since 08/22/25 | +27.82% since 08/22/25 |
| Low | 1.2500 on 08/22/23 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 2.4400 on 04/17/23 | 212.71 on 02/18/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 62.05 on 02/06/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,540 | 316,695,392 | 202,015,744 | 187,838,960 | 123,532,512 |
| Shares Outstanding, K | 1,868 | 1,550,908 | 539,068 | 1,240,680 | 2,036,474 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -5,800,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -3,760,000 | 2,326,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 2.37 | 0.34 | 0.46 | 0.36 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.11 on 08/11/23 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 11/29/23 | 05/05/26 | 05/07/26 | 04/23/26 | 04/23/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 02/13/26 | 03/13/26 | 01/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 25.76 | 17.19 | 18.54 | 9.80 |